Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.

Caduff, Nicole; McHugh, Donal; Murer, Anita; Rämer, Patrick; Raykova, Ana; Landtwing, Vanessa; Rieble, Lisa; Keller, Christian W; Prummer, Michael; Hoffmann, Laurent; Lam, Janice K P; Chiang, Alan K S; Raulf, Friedrich; Azzi, Tarik; Berger, Christoph; Rubic-Schneider, Tina; Traggiai, Elisabetta; Lünemann, Jan D; Kammüller, Michael; Münz, Christian

Caduff, Nicole; McHugh, Donal; Murer, Anita; Rämer, Patrick; Raykova, Ana; Landtwing, Vanessa; Rieble, Lisa; Keller, Christian W; Prummer, Michael; Hoffmann, Laurent; Lam, Janice K P; Chiang, Alan K S; Raulf, Friedrich; Azzi, Tarik; Berger, Christoph; Rubic-Schneider, Tina; Traggiai, Elisabetta; Lünemann, Jan D; Kammüller, Michael; Münz, Christian.

PLoS Pathog ; 16(12): e1009167, 2020 Dec.

Article in En | MEDLINE | ID: mdl-33347498

ABSTRACT

ABSTRACT

[This corrects the article DOI 10.1371/journal.ppat.1008477.].

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: PLoS Pathog Year: 2020 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: PLoS Pathog Year: 2020 Type: Article